{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ehrlich ascites carcinoma", "acute oral toxicity", "anticancer", "antitubulin", "indanocine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33969634", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1111/cbdd.13857"], "Journal": {"ISSN": "1747-0285", "JournalIssue": {"Volume": "98", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Chemical biology & drug design", "ISOAbbreviation": "Chem Biol Drug Des"}, "ArticleTitle": "An improved synthesis of indanocine and antiproliferative activity of 2-benzylindanocine via microtubule destabilization.", "Pagination": {"StartPage": "127", "EndPage": "143", "MedlinePgn": "127-143"}, "Abstract": {"AbstractText": ["Indanocine, a potent anticancer investigational drug of National Cancer Institute-USA, has been much discussed in recent years. Present communication aimed at total synthesis of indanocine and its close analogues. Total synthesis was improved by double yields than previously reported yields. Some of the benzylidene and 2-benzyl derivatives with free rotation at C2 position exhibited potential cytotoxicities against various human cancer cell lines. Five such analogues exhibited potential antiproliferative effect against HCT-116 and MIA PACA-2 cell lines. Benzylindanocine 12i induced microtubule destabilization by occupying colchicine binding pocket of \u03b2-tubulin. It also exhibited anti-inflammatory activity by down-regulating IL-6 and TNF-\u03b1. In Ehrlich ascites carcinoma model, 12i reduced 78.4% of EAC tumour in Swiss albino mice at 90\u00a0mg/kg (i.p.) dose. Further, in in vivo safety studies, 12i was found to be safe to rodents up to 1,000\u00a0mg/kg dose. Concomitant anticancer and anti-inflammatory activity of benzylindanocine is distinctive, which suggests its further optimization for better efficacy and druggability."], "CopyrightInformation": "\u00a9 2021 John Wiley & Sons A/S."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Khwaja", "ForeName": "Sadiya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Fatima", "ForeName": "Kaneez", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}], "LastName": "Mishra", "ForeName": "Divya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}], "LastName": "Babu", "ForeName": "Vineet", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}], "LastName": "Kumar", "ForeName": "Yogesh", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, India."}], "LastName": "Malik", "ForeName": "Sumera Banu", "Initials": "SB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, India."}], "LastName": "Tabassum", "ForeName": "Misbah", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Bawankule", "ForeName": "Dnyaneshwar U", "Initials": "DU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Chanda", "ForeName": "Debabrata", "Initials": "D"}, {"Identifier": ["0000-0002-2704-5925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}, {"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, India."}], "LastName": "Mondhe", "ForeName": "Dilip M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) P.O. CIMAP, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Negi", "ForeName": "Arvind S", "Initials": "AS"}], "GrantList": [{"Agency": "Council of Scientific and Industrial Research, India", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chem Biol Drug Des", "NlmUniqueID": "101262549", "ISSNLinking": "1747-0277"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylidene Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Indans"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "indanocine"}, {"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Benzylidene Compounds"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Colchicine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Indans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microtubules"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tubulin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akindele, A. J., Wani, Z., Mahajan, G., Sharma, S., Aigbe, F. R., Satti, N., Adeyemi, O. O., & Mondhe, D. M. (2015). Anticancer activity of Aristolochia ringens Vahl. (Aristolochiaceae). Journal of Traditional and Complementary Medicine, 5, 35-41. https://doi.org/10.1016/j.jtcme.2014.05.001"}, {"Citation": "Baell, J., & Walters, M. A. (2014). Chemistry: Chemical con artists foil drug discovery. Nature, 513, 481-483. https://doi.org/10.1038/513481a"}, {"Citation": "Beams, H. W., & Kessel, R. G. (1968). Properties of the Ehrlich Ascites tumor cell as determined by electron microscopy, ultracentrifugation, and hydrostatic pressure. Cancer Research, 28, 1944-1951."}, {"Citation": "Burns, R. G. (1992). Analysis of the colchicine-binding site of beta-tubulin. FEBS Journal, 297, 205-208."}, {"Citation": "Carson, D. A., Shih, C. H., Cottam, H. B., & Leoni, L. (2000). Indanone tetralone compounds for inhibiting cell proliferation. US Pat., 6, 162810."}, {"Citation": "Chai, E. Z. P., Siveen, K. S., Shanmugam, M. K., Arfuso, F., & Sethi, G. (2015). Analysis of the intricate relationship between chronic inflammation and cancer. The Biochemical Journal, 468, 1-15. https://doi.org/10.1042/BJ20141337"}, {"Citation": "Chanda, D., Shanker, K., Pal, A., Luqman, S., Bawankule, D. U., Mani, D. N., & Darokar, M. P. (2009). Safety evaluation of Trikatu, a generic Ayurvedic medicine in Charles Foster rats. Journal of Toxicological Sciences, 34, 99-108. https://doi.org/10.2131/jts.34.99"}, {"Citation": "Coulup, S. K., & George, G. I. (2019). Revisiting microtubule targeting agents: \u03b1-tubulin and the pironetin binding site as unexplored targets for cancer therapeutics. Bioorganic & Medicinal Chemistry Letters, 29, 1865-1873. https://doi.org/10.1016/j.bmcl.2019.05.042"}, {"Citation": "Das, L., Gupta, S., Dasgupta, D., Poddar, A., Janik, M. E., & Bhattacharyya, B. (2009). Binding of indanocine to the colchicine site on tubulin promotes fluorescence, and its binding parameters resemble those of the colchicine analogue AC. Biochemistry, 48, 1628-1635."}, {"Citation": "Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., Miller, A. H., Mantovani, A., Weyand, C. M., Barzilai, N., Goronzy, J. J., Rando, T. A., Effros, R. B., Lucia, A., Kleinstreuer, N., & Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25, 1822-1832. https://doi.org/10.1038/s41591-019-0675-0"}, {"Citation": "Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018). Interleukin-6: Designing specific therapeutics for the complex cytokine. Nature Reviews Drug Discovery, 17, 395-412."}, {"Citation": "Huang, L., Lu, C., Sun, Y., Mao, F., Luo, Z., Su, T., Jiang, H., Shan, W., & Li, X. (2012). Multitarget-directed benzylideneindanone derivatives: Anti-\u03b2-amyloid (A\u03b2) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. Journal of Medicinal Chemistry, 55, 8483-8492. https://doi.org/10.1021/jm300978h"}, {"Citation": "Kapoor, S., & Panda, D. (2012). Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells. Biochemical Pharmacology, 83, 1495-1506. https://doi.org/10.1016/j.bcp.2012.02.012"}, {"Citation": "Kaul, R., Risinger, A. L., & Mooberry, S. L. (2019). Microtubule-targeting drugs: More than antimitotics. Journal of Natural Products, 82, 680-685. https://doi.org/10.1021/acs.jnatprod.9b00105"}, {"Citation": "Kenakin, T. P. (2017). Book: Pharmacology in drug discovery and development. Chapter 7: Pharmacokinetics I: Permeation and metabolism\u201d, 2nd ed. (pp. 157-191). Academic Press, Elsevier Inc."}, {"Citation": "Lee, J. C., & Timassheff, S. N. (1997). In vitro reconstitution of calf brain microtubules: Effects of solution variables. Biochemistry, 16, 1754-1764. https://doi.org/10.1021/bi00627a037"}, {"Citation": "Leoni, L. M., Hamel, E., Genini, D., Shih, H., Carrera, C. J., Cottam, H. B., & Carson, D. A. (2000). Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. Journal of the National Cancer Institute, 92, 217-224. https://doi.org/10.1093/jnci/92.3.217"}, {"Citation": "Negi, A. S., Gautam, Y., Alam, S., Chanda, D., Luqman, S., Sarkar, J., Khan, F., & Konwar, R. (2015). Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment. Bioorganic & Medicinal Chemistry, 23, 373-389. https://doi.org/10.1016/j.bmc.2014.12.027"}, {"Citation": "Pathak, N., Fatima, K., Singh, S., Mishra, D., Gupta, A. C., Kumar, Y., Chanda, D., Bawankule, D. U., Shanker, K., Khan, F., Gupta, A., Luqman, S., & Negi, A. S. (2019). Bivalent furostene carbamates as antiproliferative and antiinflammatory agents. The Journal of Steroid Biochemistry and Molecular Biology, 194, 105457."}, {"Citation": "Shih, H. C., Deng, L., Carrera, C. J., Adachi, S., Cottam, H. B., & Carson, D. A. (2000). Rational design, synthesis and structure-activity relationships of antitumore (E)-2-benzylidene-1-tetralones and (E)-2-benzylidene-1-indanones. Bioorganic & Medicinal Chemistry Letters, 10, 487-490."}, {"Citation": "Swiss Institute of Bioinformatics. (2019). http://www.swissadme.ch/. Accessed date 26/04/2020"}, {"Citation": "Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455-461."}, {"Citation": "Tunbridge, G. A., Oram, J., & Caggiano, L. (2013). Design, synthesis and antiproliferative activity of indole analogues of indanocine. MedChemComm, 4, 1452-1456. https://doi.org/10.1039/c3md00200d"}, {"Citation": "WHO. (2002). The importance of pharmacovigilance, safety monitoring of medicinal products. World Health Organization."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "4", "Day": "8"}, {"Year": "2021", "Month": "2", "Day": "16"}, {"Year": "2021", "Month": "5", "Day": "1"}, {"Year": "2021", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "10", "Hour": "6", "Minute": "51"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33969634", "10.1111/cbdd.13857"]}}], "PubmedBookArticle": []}